Deutsche Bank’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $193M | Sell |
894,035
-169,793
| -16% | -$32.5M | 0.06% | 315 |
|
|
2026
Q1 | $195M | Buy |
1,063,828
+110,100
| +12% | +$20.3M | 0.06% | 283 |
|
|
2025
Q4 | $168M | Sell |
953,728
-277,574
| -23% | -$45.3M | 0.05% | 317 |
|
|
2025
Q3 | $172M | Buy |
1,231,302
+108,124
| +10% | +$14.6M | 0.06% | 306 |
|
|
2025
Q2 | $141M | Buy |
1,123,178
+182,126
| +19% | +$22.7M | 0.05% | 335 |
|
|
2025
Q1 | $129M | Sell |
941,052
-228,518
| -20% | -$32.7M | 0.05% | 350 |
|
|
2024
Q4 | $179M | Buy |
1,169,570
+455,285
| +64% | +$76.8M | 0.07% | 262 |
|
|
2024
Q3 | $138M | Buy |
714,285
+60,612
| +9% | +$12.7M | 0.06% | 320 |
|
|
2024
Q2 | $152M | Sell |
653,673
-403,788
| -38% | -$87.8M | 0.07% | 249 |
|
|
2024
Q1 | $228M | Sell |
1,057,461
-132,429
| -11% | -$31M | 0.11% | 182 |
|
|
2023
Q4 | $308M | Buy |
1,189,890
+253,408
| +27% | +$62.2M | 0.16% | 137 |
|
|
2023
Q3 | $241M | Sell |
936,482
-268,701
| -22% | -$71.9M | 0.16% | 135 |
|
|
2023
Q2 | $343M | Sell |
1,205,183
-436,565
| -27% | -$130M | 0.18% | 122 |
|
|
2023
Q1 | $456M | Sell |
1,641,748
-209,366
| -11% | -$57.9M | 0.25% | 91 |
|
|
2022
Q4 | $513M | Buy |
1,851,114
+247,691
| +15% | +$70M | 0.3% | 86 |
|
|
2022
Q3 | $428M | Sell |
1,603,423
-63,476
| -4% | -$13.5M | 0.26% | 91 |
|
|
2022
Q2 | $340M | Buy |
1,666,899
+227,008
| +16% | +$46.4M | 0.19% | 113 |
|
|
2022
Q1 | $303M | Sell |
1,439,891
-126,329
| -8% | -$27.5M | 0.14% | 146 |
|
|
2021
Q4 | $376M | Buy |
1,566,220
+184,738
| +13% | +$47.5M | 0.17% | 130 |
|
|
2021
Q3 | $391M | Sell |
1,381,482
-33,712
| -2% | -$11M | 0.19% | 125 |
|
|
2021
Q2 | $490M | Buy |
1,415,194
+128,955
| +10% | +$39.1M | 0.24% | 89 |
|
|
2021
Q1 | $360M | Buy |
1,286,239
+284,571
| +28% | +$76.7M | 0.19% | 108 |
|
|
2020
Q4 | $245M | Sell |
1,001,668
-178,143
| -15% | -$46M | 0.15% | 138 |
|
|
2020
Q3 | $335M | Buy |
1,179,811
+169,069
| +17% | +$47.2M | 0.23% | 93 |
|
|
2020
Q2 | $270M | Sell |
1,010,742
-57,942
| -5% | -$17.4M | 0.21% | 101 |
|
|
2020
Q1 | $338M | Sell |
1,068,684
-303,099
| -22% | -$92M | 0.3% | 69 |
|
|
2019
Q4 | $407M | Sell |
1,371,783
-421,690
| -24% | -$117M | 0.27% | 76 |
|
|
2019
Q3 | $418M | Buy |
1,793,473
+77,240
| +5% | +$18M | 0.29% | 73 |
|
|
2019
Q2 | $401M | Sell |
1,716,233
-399,556
| -19% | -$92.3M | 0.24% | 77 |
|
|
2019
Q1 | $500M | Buy |
2,115,789
+871,960
| +70% | +$275M | 0.3% | 63 |
|
|
2018
Q4 | $374M | Sell |
1,243,829
-423,325
| -25% | -$135M | 0.27% | 76 |
|
|
2018
Q3 | $589M | Buy |
1,667,154
+9,032
| +0.5% | +$3.11M | 0.3% | 58 |
|
|
2018
Q2 | $481M | Sell |
1,658,122
-1,860,095
| -53% | -$523M | 0.24% | 76 |
|
|
2018
Q1 | $963M | Buy |
3,518,217
+2,253,559
| +178% | +$700M | 0.46% | 38 |
|
|
2017
Q4 | $403M | Sell |
1,264,658
-311,943
| -20% | -$100M | 0.26% | 81 |
|
|
2017
Q3 | $494M | Sell |
1,576,601
-88,975
| -5% | -$26.3M | 0.34% | 55 |
|
|
2017
Q2 | $452M | Buy |
1,665,576
+69,431
| +4% | +$18.4M | 0.32% | 60 |
|
|
2017
Q1 | $436M | Buy |
1,596,145
+101,331
| +7% | +$28.7M | 0.32% | 67 |
|
|
2016
Q4 | $424M | Sell |
1,494,814
-246,542
| -14% | -$73.1M | 0.34% | 58 |
|
|
2016
Q3 | $545M | Sell |
1,741,356
-61,383
| -3% | -$18.2M | 0.39% | 50 |
|
|
2016
Q2 | $436M | Buy |
1,802,739
+561,181
| +45% | +$148M | 0.31% | 67 |
|
|
2016
Q1 | $323M | Sell |
1,241,558
-111,720
| -8% | -$29.5M | 0.24% | 88 |
|
|
2015
Q4 | $415M | Buy |
1,353,278
+223,211
| +20% | +$64.1M | 0.29% | 70 |
|
|
2015
Q3 | $330M | Buy |
1,130,067
+23,746
| +2% | +$7.84M | 0.25% | 80 |
|
|
2015
Q2 | $447M | Sell |
1,106,321
-284
| -0% | -$114K | 0.29% | 70 |
|
|
2015
Q1 | $467M | Buy |
1,106,605
+156,688
| +16% | +$61.8M | 0.29% | 76 |
|
|
2014
Q4 | $322M | Buy |
949,917
+57,649
| +6% | +$18.7M | 0.2% | 105 |
|
|
2014
Q3 | $295M | Sell |
892,268
-76,451
| -8% | -$25.2M | 0.18% | 119 |
|
|
2014
Q2 | $305M | Buy |
968,719
+72,226
| +8% | +$21.7M | 0.21% | 97 |
|
|
2014
Q1 | $274M | Sell |
896,493
-137,618
| -13% | -$43.7M | 0.19% | 113 |
|
|
2013
Q4 | $289M | Sell |
1,034,111
-477,574
| -32% | -$124M | 0.21% | 105 |
|
|
2013
Q3 | $364M | Buy |
1,511,685
+797,677
| +112% | +$179M | 0.27% | 68 |
|
|
2013
Q2 | $154M | Buy |
+714,008
| New | +$153M | 0.13% | 195 |
|
Other funds holding BIIB
Deutsche Bank's BIIB Position: Q2 2026 in Review
Deutsche Bank reduced its Biogen (BIIB) stake by 16% in Q2 2026, selling an estimated $32.5M and leaving 894,035 shares worth $193M. The position accounts for 0.06% of the portfolio, ranked #315.
Deutsche Bank first reported a position in BIIB in Q2 2013 and has held it in 53 quarters since. The position peaked at $963M in Q1 2018. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Deutsche Bank held 894,035 shares of Biogen worth $193M as of Q2 2026.
- Deutsche Bank sold 169,793 Biogen shares in Q2 2026, an estimated $32.5M.
- Biogen made up 0.06% of Deutsche Bank's portfolio in Q2 2026, its #315 holding.
- Deutsche Bank first reported a position in Biogen in Q2 2013 and has held it in 53 quarters since.
- Deutsche Bank's Biogen position peaked at $963M in Q1 2018.
- 1,041 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.